Please login to the form below
Cell Therapeutics Inc
This page shows the latest Cell Therapeutics Inc news and features for those working in and with pharma, biotech and healthcare.
CTI launches cancer drug Pixuvri in UK
Now available to treat form of non-Hodgkin lymphoma. Cell Therapeutics Inc (CTI) has launched its cancer treatment Pixuvri in the UK. ... Pixuvri (pixantrone) becomes the first drug available in the UK as a monotherapy treatment option for adults with
Latest news
-
Baxter licenses cancer drug from CTI in $172m deal
Pacritinib is being investigated to treat blood disorder myelofibrosis. Cell Therapeutics Inc (CTI) has met its objective of finding a commercial partner for cancer candidate pacritinib by the end of the
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Deal Watch February 2016
licence, collaboration expanded. 830. Adaptimmune Therapeutics/ GSK. TCR engineered T-cell therapies inc affinity enhanced T-cell immunotherapy targeting NY-ESO-1 (p1/2); 4 other progs and combination studies. ... acquisition - product. 190. Annapurna
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Content Editor - Biotechnology
-
Salary TBC
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC
- Saturnino Izquierdo takes on expanded role at McCann Health
- J&J delays EU COVID-19 vaccine rollout following pause in the US
- Moderna’s booster vaccine for South African variant demonstrates promising early results
- UK trial evaluating mixed-vaccine regimens includes two more jabs
- Follow the user – democratising medical conference design
PMHub
Aurora Healthcare Communications
We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...
Latest intelligence
- How a design mindset can lead to better medical outcomes
- By adopting a design philosophy, healthcare companies can develop communications that allow healthcare professionals (HCPs) to better meet the needs of their patients. Imaginatively designed content combined with patient insights...
- How does the government plan to reshape the NHS?
- Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care...
- Want to give perfect client service? Tough luck, you’re human
- In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
Quick links
Infographics
